Trials / Completed
CompletedNCT03178708
Amantadine Sulphate Usage in Spine Deformities Corrective Surgeries Patients
The Implications of Amantadine Sulphate Usage in Spine Deformities Corrective Surgeries Patients as Regard Its Effect on the Duration of Wake up Test and Postoperative Opioid Consumption
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Assiut University · Academic / Other
- Sex
- All
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
During the surgical procedure of scoliosis correction, large surgery extent and long-lasting strong nociceptive stimulation lead to postoperative pain formation of greater intensity compared with other orthopedic interventions. In these patients, duration of postoperative symptoms is longer, and may lead to persistent pain formation due to developing neuroplastic changes in the central nervous system.
Detailed description
Instrumentation in correction operations for spinal deformities as vertebral fusion, congenital and traumatic scoliosis, carries a 0.5-5% risk of injuring the spinal cord during spinal surgery. These complications are generally results of complex factors such as direct effects of compression on the spinal cord, distraction, the effects of spinal ischemia or arterial hypotension. The purpose of the wake-up test is to monitor voluntary motor function of the lower limbs once the vertebrae have been instrumented and distracted. The depth of anesthesia is gradually lightened up to the point where patients are able to respond to verbal commands. As the voluntary movement of lower extremities is demonstrated, the depth of anesthesia is increased to complete the surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Group A amantadine sulfate | infusion solution for slowly intravenous application 3 hours preoperative |
| OTHER | Group B ringer lactate | infusion solution for intravenous application 3 hours preoperative |
Timeline
- Start date
- 2017-08-01
- Primary completion
- 2019-12-30
- Completion
- 2019-12-30
- First posted
- 2017-06-07
- Last updated
- 2021-01-12
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03178708. Inclusion in this directory is not an endorsement.